ZHONGSHENGYAOYE(SZ:002317) Xin Lang Cai Jing·2025-09-18 01:24Core Insights - On September 17, Zhongsheng Pharmaceutical experienced a decline of 0.45% with a trading volume of 531 million yuan, indicating a slight decrease in market performance [1] - As of June 30, 2025, Zhongsheng Pharmaceutical reported a revenue of 1.3 billion yuan, a year-on-year decrease of 4.74%, while net profit attributable to shareholders increased by 114.96% to 188 million yuan [2] Financing and Margin Trading - On September 17, the financing buy-in amount for Zhongsheng Pharmaceutical was 50.95 million yuan, with a net financing outflow of 2.53 million yuan, indicating a higher level of financing activity [1] - The total margin trading balance for Zhongsheng Pharmaceutical reached 553 million yuan, accounting for 3.22% of its market capitalization, which is above the 70th percentile of the past year [1] Shareholder and Institutional Holdings - As of June 30, 2025, the number of shareholders for Zhongsheng Pharmaceutical was 89,900, a decrease of 1.32% from the previous period, while the average number of circulating shares per person increased by 1.33% to 8,470 shares [2] - The company has distributed a total of 2.019 billion yuan in dividends since its A-share listing, with 502 million yuan distributed over the past three years [3] - Among the top ten circulating shareholders, Hong Kong Central Clearing Limited is the fourth largest with 9.1731 million shares, marking its entry as a new shareholder [3]